Resources search

Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief, 19 April 2021

WORLD HEALTH ORGANISATION (WHO)
UNITED NATIONS CHILDREN'S FUND (UNICEF)
Eds
April 2021

Expand view

Persons with disabilities are disproportionately impacted by COVID-19, both directly because of infection, and indirectly because of restrictions to reduce the spread of the virus. Persons with disabilities are a diverse group, and the risks, barriers and impacts faced by them will vary in different contexts according to, among other factors, their age, gender identity, type of disability, ethnicity, sexual orientation, and migration status.

This document presents considerations and actions for the following stakeholders to ensure equity in access to vaccination against COVID‑19 for persons with disabilities:

− Persons with disabilities and their support networks

− Governments

− Health service providers delivering vaccinations

− Organizations of persons with disabilities

− Disability service providers

− Residential institutions and long-term care facilities

− Community

Assistive technology in Tajikistan: Situational analysis

WORLD HEALTH ORGANISATION (WHO). REGIONAL OFFICE FOR EUROPE
2019

Expand view

"This publication summarizes the current gaps, needs and opportunities for intervention in the field of assistive technology in Tajikistan. The situational analysis was conducted under the leadership of the Ministry of Health and Social Protection, Republic of Tajikistan and with technical support from the WHO Country Office, Tajikistan. It was undertaken in collaboration with different Government ministries and State agencies, development partners, United Nations agencies, nongovernmental organizations, disabled people’s organizations and users of assistive products. It adopted a realist synthesis approach, responsive to the unique social, cultural, economic and political circumstances in the country. The evaluation focuses on assistive technology policy and governance, service provision and the impact of assistive technology on the health and well-being of individual users and their families, with the aim of improving access to high-quality, affordable assistive products in Tajikistan.

 

200 persons with disabilities participated in a survey designed to collect information on self-reported need for assistive products, user experiences and barriers to access. An additional 11 focus groups made up of persons with disabilities and older adults held indepth discussions on assistive technology. The major providers of assistive technology (Government facilities, nongovernmental organizations, local producers) were also interviewed as part of the research"

Provision of wheelchairs in Tajikistan: Economic assessment of alternative options

WORLD HEALTH ORGANISATION (WHO). REGIONAL OFFICE FOR EUROPE
2019

Expand view

"This publication presents the results of a study on the economic aspects of various models for the provision of wheelchairs in Tajikistan. The study was conducted under the leadership of the Ministry of Health and Social Protection, Republic of Tajikistan and with technical support from the WHO Country Office, Tajikistan. The study was finalized in consultation with Tajik users of wheelchairs, the Ministry of Health and Social Protection and international experts on wheelchair production and provision, and made use of national and international evidence on the provision of wheelchairs to inform the analysis and develop evidence-based policy options. While the study focuses on the Tajik context and its aspirations to expand in-country production of wheelchairs, its approach and findings will also be of interest to other countries in a similar situation and to other interested stakeholders"

 

 

Managing epidemics - Key facts about major deadly diseases

WORLD HEALTH ORGANISATION (WHO)
2018

Expand view

The manual is structured in three parts.

  • Part One “Epidemics of the 21st century” provides vital insights on the main features of the 21st century upsurge and the indispensable elements to manage them.
  • Part Two “Be in the know. 10 key facts about 15 deadly diseases” contains key information about 15 diseases (Ebola Virus Disease, Lassa Fever, Crimean-Congo haemorrhagic fever, Yellow Fever, Zika, Chikungunya, Avian and Other Zoonotic Influenza, Seasonal Influenza, Pandemic Influenza, Middle East Respiratory Syndrome, Cholera, Monkeypox, Plague, Leptospirosis and Meningococcal Meningitis). This section provides tips on the interventions required to respond to epidemics of all these diseases.
  • Part Three “Tool boxes” gives an overview and summarized guidance on some other important topics, including: the role of WHO, the International Coordinating Group, laboratory diagnosis and shipment of infectious diseases substances, and vector control.

 

The handbook enables the three levels of WHO – its Headquarters, Regional Offices and Country Offices to work efficiently together by building the foundations of a shared conceptual and thinking framework, which includes common terminology. 

International perspectives on spinal cord injury

BICKENBACH, Jerome
et al
Eds
2013

Expand view

This report assembles and summarizes information on spinal cord injury, in particular the epidemiology, services, interventions and policies that are relevant, together with the lived experience of people with spinal cord injury. It also provides recommendations for actions based on this evidence that are consistent with the aspirations for people with disabilities as expressed in the Convention on the Rights of Persons with Disabilities

Global status report on noncommunicable diseases 2010

WORLD HEALTH ORGANIZATION (WHO)
2011

Expand view

"This report sets out the statistics, evidence and experiences needed to launch a more forceful response to the growing threat posed by noncommunicable diseases. While advice and recommendations are universally relevant, the report gives particular attention to conditions in low- and middle-income countries, which now bear nearly 80% of the burden from diseases like cardiovascular disease, diabetes, cancer and chronic respiratory diseases. The health consequences of the worldwide epidemic of obesity are also addressed"

Priority medicines for mothers and children 2011

WORLD HEALTH ORGANIZATION (WHO)
2011

Expand view

This resource presents a list of priority medicines for mothers and children to help countries and partners select and make available those medicines that will have the biggest impact on reducing maternal, newborn and child morbidity and mortality
WHO/EMP/MAR/2011.1

World health statistics 2010

WORLD HEALTH ORGANIZATION (WHO)
2010

Expand view

This annual compilation of health-related data for the World Health Organization's 193 member states, includes a summary of the progress made towards achieving the health-related Millennium Development Goals (MDGs) and associated targets

Culture and mental health in Haiti : a literature review

WORLD HEALTH ORGANIZATION (WHO)
2010

Expand view

"This paper reviews and summarizes the available literature on Haitian mental health and Mental health services. This review was conducted in light of the Haitian earthquake in January 2010. The first part of the review describes historical, economic, sociological and anthropological factors essential to basic understanding of Haiti and its people. This includes discussion of demography, family structure, Haitian economics and religion. The second part of the review focuses on mental health and mental health services. This includes a review of factors such as basic epidemiology of mental illness, common beliefs about mental illness, explanatory models, idioms of distress, help-seeking behavior, configuration of mental health services and the relationship between religion and mental health"

Treatment of tuberculosis guidelines

WORLD HEALTH ORGANIZATION (WHO)
2010

Expand view

These guidelines aim ..."to help national tuberculosis (TB) control programmes in setting TB treatment policy to optimise patient cure: curing patients will prevent death, relapse, acquired drug resistance, and the spread of TB in the community. Their further purpose is to guide clinicians working in both public and private sectors." This new edition of the guidelines integrates the detection and treatment of both HIV infection and multi-drug resistant TB

Medicines : corruption and pharmaceuticals

WORLD HEALTH ORGANIZATION (WHO)
December 2009

Expand view

This fact sheet gives a brief overview of the key facts regarding corruption in the pharmaceutical supply chain. It focuses on unethical practices in the medicines supply chain, factors contributing to pharmaceutical corruption, the impact of corruption, and the response of the WHO

Medicines use in primary care in developing and transitional countries : fact book summarizing results from studies reported between 1990 and 2006

WORLD HEALTH ORGANIZATION (WHO)
May 2009

Expand view

Irrational use of medicines is one of the most serious global public health problems we face today. Improving use requires regular monitoring and application of effective interventions, both of which are often not done, particularly in many lower income countries. To address this issue, WHO created a database of medicines use in in primary care settings in developing and transitional countries. Quantitative information has been extracted from 679 studies conducted in 97 countries and on 386 interventions (from 313 studies). The medicines use database has allowed the first systematic quantitative review of studies measuring medicines use in developing and transitional countries and the results are now presented

WHO model list of essential medicines for children

WORLD HEALTH ORGANIZATION (WHO)
March 2009

Expand view

The medicines in this model list are intended for use for children up to the age of 12. There is a core list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and cost-effective medicines for priority conditions. Priority conditions are selected on the basis of current and estimated future public health relevance, and potential for safe and cost-effective treatment. There is also a complementary list of essential medicines for priority diseases, for which specialised diagnostic or monitoring facilities, and/or specialist medical care, and/or specialist training are needed

World malaria report 2009

WORLD HEALTH ORGANIZATION (WHO)
2009

Expand view

This report summarises information received from 108 malaria endemic countries and other sources and updates the analysis presented in the 2008 Report. It highlights progress made in meeting the World Health Assembly (WHA) targets for malaria to be achieved by 2010 and 2015, and new goals on malaria elimination contained in the Global Malaria Action Plan (2008)

WHO handbook on indoor radon : a public health perspective

ZEEB, Hajo
SHANNOUN, Ferid
2009

Expand view

This handbook focuses on residential radon exposure from a public health point of view and provides detailed recommendations on reducing health risks from radon and policy options for preventing and mitigating radon exposure. The material reflects the epidemiological evidence that indoor radon exposure is responsible for a substantial number of lung cancers in the general population

Measuring transparency in the public pharmaceutical sector : assement instrument

BAGHDADI-SABETI, Guitelle
COHEN-KOHLER, John Clare
WONDEMAGEGNEHU, Eshetu
2009

Expand view

The objective of this instrument is to help stakeholders carry out assessments to measure the level of transparency and the vulnerability to corruption in selected areas of the public pharmaceutical sector. It provides an assessment methodology together with a questionnaire for national assessors to systematically collect information and perceptions through interviews of relevant health professionals in the public and private sectors

Community-based surveillance of antimicrobial use and resistance in resource-constrained settings|Report on five pilot projects

HOLLOWAY, Kathleen A
2009

Expand view

This document describes five pilot surveillance projects that were set up in India (three sites) and South Africa (two sites) with the aim of developing a model for undertaking integrated community-based surveillance in resource-constrained settings and generating baseline data. The methodology used in each area aimed to collect antimicrobial resistance (AMR) and use data from the same geographical area over time, but was modified to suit the particular characteristics of each site

Pages

E-bulletin